BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26972162)

  • 1. Differential network analysis reveals the genome-wide landscape of estrogen receptor modulation in hormonal cancers.
    Hsiao TH; Chiu YC; Hsu PY; Lu TP; Lai LC; Tsai MH; Huang TH; Chuang EY; Chen Y
    Sci Rep; 2016 Mar; 6():23035. PubMed ID: 26972162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide identification of key modulators of gene-gene interaction networks in breast cancer.
    Chiu YC; Wang LJ; Hsiao TH; Chuang EY; Chen Y
    BMC Genomics; 2017 Oct; 18(Suppl 6):679. PubMed ID: 28984209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SERPINA1 is a direct estrogen receptor target gene and a predictor of survival in breast cancer patients.
    Chan HJ; Li H; Liu Z; Yuan YC; Mortimer J; Chen S
    Oncotarget; 2015 Sep; 6(28):25815-27. PubMed ID: 26158350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
    Verbeke LP; Van den Eynden J; Fierro AC; Demeester P; Fostier J; Marchal K
    PLoS One; 2015; 10(7):e0133503. PubMed ID: 26217958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMRF-MI: integrative identification of protein interaction network by modeling the gene dependency.
    Shi X; Wang X; Shajahan A; Hilakivi-Clarke L; Clarke R; Xuan J
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S10. PubMed ID: 26099273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistical identification of gene association by CID in application of constructing ER regulatory network.
    Liu LY; Chen CY; Chen MJ; Tsai MS; Lee CH; Phang TL; Chang LY; Kuo WH; Hwa HL; Lien HC; Jung SM; Lin YS; Chang KJ; Hsieh FJ
    BMC Bioinformatics; 2009 Mar; 10():85. PubMed ID: 19292896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modular analysis of breast cancer reveals a novel low-grade molecular signature in estrogen receptor-positive tumors.
    Yu K; Ganesan K; Miller LD; Tan P
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3288-96. PubMed ID: 16740749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FGMD: A novel approach for functional gene module detection in cancer.
    Jin D; Lee H
    PLoS One; 2017; 12(12):e0188900. PubMed ID: 29244808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-modulation analysis of gene regulation in breast cancer reveals complex interplay between ESR1 and ERBB2 genes.
    Chiu YC; Wu CT; Hsiao TH; Lai YP; Hsiao C; Chen Y; Chuang EY
    BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S19. PubMed ID: 26100352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and functional annotation of genome-wide ER-regulated genes in breast cancer based on ChIP-Seq data.
    Ding M; Wang H; Chen J; Shen B; Xu Z
    Comput Math Methods Med; 2012; 2012():568950. PubMed ID: 23346221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative network analysis for survival-associated gene-gene interactions across multiple genomic profiles in ovarian cancer.
    Jeong HH; Leem S; Wee K; Sohn KA
    J Ovarian Res; 2015 Jul; 8():42. PubMed ID: 26138921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression signature of estrogen receptor alpha status in breast cancer.
    Abba MC; Hu Y; Sun H; Drake JA; Gaddis S; Baggerly K; Sahin A; Aldaz CM
    BMC Genomics; 2005 Mar; 6():37. PubMed ID: 15762987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topologically inferring pathway activity for precise survival outcome prediction: breast cancer as a case.
    Liu W; Wang W; Tian G; Xie W; Lei L; Liu J; Huang W; Xu L; Li E
    Mol Biosyst; 2017 Feb; 13(3):537-548. PubMed ID: 28098303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel framework for inferring condition-specific TF and miRNA co-regulation of protein-protein interactions.
    Zhang J; Le TD; Liu L; He J; Li J
    Gene; 2016 Feb; 577(1):55-64. PubMed ID: 26611531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extensive rewiring of epithelial-stromal co-expression networks in breast cancer.
    Oh EY; Christensen SM; Ghanta S; Jeong JC; Bucur O; Glass B; Montaser-Kouhsari L; Knoblauch NW; Bertos N; Saleh SM; Haibe-Kains B; Park M; Beck AH
    Genome Biol; 2015 Jun; 16(1):128. PubMed ID: 26087699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
    Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V
    Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammosphere-derived gene set predicts outcome in patients with ER-positive breast cancer.
    Kok M; Koornstra RH; Margarido TC; Fles R; Armstrong NJ; Linn SC; Van't Veer LJ; Weigelt B
    J Pathol; 2009 Jul; 218(3):316-26. PubMed ID: 19353633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The gene regulatory networks controlled by estrogens.
    Gao H; Dahlman-Wright K
    Mol Cell Endocrinol; 2011 Mar; 334(1-2):83-90. PubMed ID: 20837099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells.
    Lin CY; Ström A; Vega VB; Kong SL; Yeo AL; Thomsen JS; Chan WC; Doray B; Bangarusamy DK; Ramasamy A; Vergara LA; Tang S; Chong A; Bajic VB; Miller LD; Gustafsson JA; Liu ET
    Genome Biol; 2004; 5(9):R66. PubMed ID: 15345050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.